RND - ETF AI Analysis
Top Page
First Trust Bloomberg R&D Leaders ETF (RND)
Rating:75Outperform
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains so far this year, showing positive momentum for investors.
Leading Technology and Innovation Holdings
Many of the largest positions are well-known technology and R&D-focused companies with strong recent performance, which can help drive growth.
Broad Sector Diversification Within the U.S.
The fund spreads its investments across several sectors, including technology, consumer, health care, and communication services, which helps reduce reliance on any single industry.
Negative Factors
High Concentration in a Few Mega-Cap Stocks
A small group of large companies makes up a big share of the portfolio, increasing the impact that any one stock’s moves can have on the ETF.
Mixed Performance Among Top Holdings
While some major positions have performed strongly, others have been weak or lagging, which can create uneven results for the fund.
Higher Expense Ratio Than Many Broad Market ETFs
The fund’s fee is relatively high compared with simple index ETFs, meaning more of the return is eaten up by costs over time.
RND vs. SPDR S&P 500 ETF (SPY)
AUM9.99M
RegionNorth America
Expense Ratio0.60%
Beta1.25
IssuerFirst Trust
Inception DateApr 30, 2024
Dividend YieldN/A
Asset ClassEquity
Index TrackedBloomberg R&D Leaders Select TR
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,770
30 Day Avg. Volume4,369
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
40.14Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering49
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RND Summary
The First Trust Bloomberg R&D Leaders ETF (RND) tracks the Bloomberg R&D Leaders Select TR index, focusing on U.S. companies that spend heavily on research and development. It holds many well-known innovators such as Apple and Microsoft, along with other major tech, healthcare, and consumer brands. Someone might invest in this ETF to seek long-term growth by backing companies that are trying to create new products and technologies, while also getting diversification across several sectors. A key risk is that it leans heavily toward technology and innovation-focused stocks, which can be more volatile and can go up and down sharply with market swings.
How much will it cost me?The First Trust Bloomberg R&D Leaders ETF (RND) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on companies with strong research and development initiatives to drive innovation and growth.
What would affect this ETF?The First Trust Bloomberg R&D Leaders ETF (RND) could benefit from continued advancements in technology and healthcare, as these sectors make up a significant portion of its holdings and are often driven by innovation and R&D spending. However, rising interest rates or economic slowdowns could negatively impact growth-focused companies like those in the ETF, particularly in sectors such as consumer cyclical and technology. Regulatory changes in healthcare or technology could also pose risks to some of its top holdings.
RND Top 10 Holdings
RND is powered by a who’s‑who of U.S. innovation, with Big Tech and chip names setting the tone. Microsoft and Nvidia are still rising, helping drive the fund, while Amazon and Alphabet are more mixed, reflecting some recent choppiness in growth and valuation worries. Apple looks steady but is losing a bit of short‑term steam, and Broadcom has been lagging, acting as a mild drag. Overall, the ETF leans heavily into U.S. technology and communication services, with a supporting cast of health care innovators like Amgen and Eli Lilly adding defensive growth.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Microsoft | 10.36% | $1.03M | $3.71T | -0.89% | 79 Outperform | |
| Nvidia | 8.91% | $884.12K | $5.55T | 32.19% | 76 Outperform | |
| Apple | 8.55% | $849.20K | $4.67T | 34.93% | 79 Outperform | |
| Amazon | 8.39% | $832.92K | $2.79T | 7.86% | 71 Outperform | |
| Alphabet Class A | 7.33% | $727.35K | $4.12T | 41.20% | 85 Outperform | |
| Meta Platforms | 4.24% | $420.64K | $1.57T | -19.88% | 76 Outperform | |
| Amgen | 4.14% | $411.00K | $236.38B | 56.17% | 77 Outperform | |
| Eli Lilly & Co | 3.70% | $367.80K | $1.08T | 49.73% | 72 Outperform | |
| Broadcom | 3.67% | $364.34K | $1.70T | 6.30% | 76 Outperform | |
| Amphenol | 3.55% | $352.81K | $204.13B | 49.77% | 78 Outperform |
RND Technical Analysis
Neutral
―
Price Trends
32.38
Positive
31.85
Positive
30.65
Positive
Market Momentum
0.15
Positive
48.60
Neutral
51.41
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RND, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 33.01, equal to the 50-day MA of 32.38, and equal to the 200-day MA of 30.65, indicating a neutral trend. The MACD of 0.15 indicates Positive momentum. The RSI at 48.60 is Neutral, neither overbought nor oversold. The STOCH value of 51.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RND.
RND Peer Comparison
Comparison Results
Performance Comparison
RND
First Trust Bloomberg R&D Leaders ETF
32.69
3.80
13.15%
BAMD
Brookstone Dividend Stock ETF
―
―
―
BUZZ
VanEck Social Sentiment ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
PFOE
Pathfinder Focused Opportunities ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents